The WHO explained Thursday that it's fielded several experiences of pretend semaglutide — the active ingredient in Novo Nordisk's Wegovy and Ozempic — in all geographic areas of the earth considering the fact that 2022. for the duration of this time, other firms can’t make generic versions from the drug, seriously limiting Opposition. and in